Klotho Neurosciences Inc - KLTO Net Assets per Single Share

Klotho Neurosciences (KLTO) - corporate logo

Klotho Neurosciences Inc (KLTO) is developing anti-aging therapy based on the Klotho protein to combat cellular senescence. The book value history on GURU.Markets illustrates the current trend, where 0.14 reflects the latest metric value. The business relies on outsourcing drug synthesis through CMOs, while a neutral geopolitical backdrop ensures the stability of clinical trials for its neuromedicine products.

ANEW Medical, Inc. (KLTO) Equity per Share: for the period 09/18/2024 - 03/11/2026

ANEW Medical - analytical breakdowns and key metrics (KLTO)

- price and consensus price forecast:
Stock Quotes ANEW Medical, Inc.|KLTO - Analyst Forecast Prices
- market capitalization data:
Market Value Klotho Neurosciences Inc|KLTO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Klotho Neurosciences|KLTO - Accounting Capitalization|Market Capitalization to Book Value Ratio anewmeds.com|KLTO - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Klotho Neurosciences Inc|KLTO - Long-Term Debt to Capital|Short-Term Debt to Equity ANEW Medical, Inc.|KLTO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Klotho Neurosciences Inc
Fundamental company valuation:anewmeds.com, KLTO
Manufactured products of ANEW Medical, Inc.

Investing in Klotho Neurosciences Inc (KLTO) requires a deep analysis of the capital structure to assess the sustainability of neurotherapy development. The current book value per share, reflecting the difference between total assets and liabilities per security, allows for an assessment of the company's intrinsic asset value. This indicator demonstrates how effectively the issuer's resources support the creation of innovative drugs to combat Parkinson's disease and aging.

Competitor analysis for Klotho Neurosciences Inc

Accounting Value per Share Biogen Corp BIIB|NBIX: Book Price of a Share|Net Assets per Single Share RGC|AXSM (axsome.com) - Net Asset Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Net Assets per Single Share|Book Value per Share AVXL|Net Assets per Single Share CeriBell (CBLL)|Net Assets per Single Share PRTA (Prothena Corporation)|ALEC: Net Assets per Single Share|ANNX - Net Asset Value per Share|Accounting Value per Share Omeros Corp. OMER|NGNE - Book Price of a Share|Book Value per Share AC Immune SA ACIU|VYGR (Voyager Therapeutics Inc) - Accounting Value of a Share|Net Assets per Single Share NMRA (Neumora Therapeutics Inc)|Net Asset Value per Share Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Accounting Value per Share|Accounting Value of a Share ACOG (alphacognition.com)|CGTX - Net Assets per Single Share|Equity per Share Inhibikase Therapeutics Inc IKT|SAVA (Cassava) - Book Value per Share|Assertio Holdings, Inc. (ASRT) - Net Asset Value per Share|COYA: Accounting Value per Share|VTGN (Vistagen) - Book Value per Share|OVID - Net Assets per Single Share|Accounting Value of a Share ABOS|CervoMed Inc - Net Assets per Single Share|Net Asset Value per Share ATHE (alteritytherapeutics.com)|Net Assets per Single Share CLNN|Net Assets per Share PepGen Inc PEPG|JUNS: Book Value per Share|RLMD - Accounting Value per Share|Annovis Bio Corp - Book Value per Share|Grace Therapeutics (GRCE) - Net Assets per Share|Book Value per Share AIFF (Firefly Neuroscience, Inc)|Net Asset Value per Share NRSN|Net Assets per Single Share Reviva Pharmaceuticals Holdings, Inc. RVPH|Equity per Share metaviatx.com (MTVA)|NeurAxis, Inc - Book Value per Share|Accounting Value per Share Helius Medical Technologies, Inc. HSDT|PASG (Passage Bio Corp) - Book Value per Share|NEUP: Net Asset Value per Share|Minerva Neurosciences, Inc. - Net Assets per Single Share|Net Assets per Share Athira Pharma Inc|ADXN - Accounting Value per Share|Accounting Value of a Share Alzamend|CYCN (Cyclerion Therapeutics) - Book Value per Share|Net Assets per Share PTIX (protagenic.com)|KTTA - Net Assets per Single Share|Equity per Share Cortigent Inc CRGT|ATXI: Book Value per Share|BCLI: Accounting Value per Share|CARA: Net Assets per Single Share|CHRO (chromocell.com) - Book Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc.|Net Assets per Single Share Intra-Cellular (ITCI)|Accounting Value per Share Longboard Pharma|Book Price of a Share MRNS (Marinus Pharma)|NKGN: Net Assets per Single Share|neurobopharma.com - Net Asset Value per Share|Sage Therapeutics (SAGE) - Net Assets per Single Share|SNPX - Equity per Share|Book Value per Share TRVN|Net Asset Value per Share Vigil Neuroscience, Inc.|WENA (Anew Medical) - Accounting Value per Share|Book Value per Share CERE